Full-Arch Implant Marketing for Oral Surgeons
Posted on 7/15/2026 by WEO Media |
How to Win Cases Without Losing Referrals
 Full-arch implant marketing for oral surgeons has to run on two tracks at once to win cases without losing referrals: a referral track that gives general dentists a documented reason to keep referring, and a direct-to-patient track that reaches edentulous and failing-dentition patients before a corporate full-arch center does—both governed by one published restorative policy stating exactly where each case goes back.
The pattern is predictable: a practice launches full-arch ads, a billboard goes up, and two quarters later the third-molar schedule is thinner. Nobody calls to complain. Referring general dentists simply read the same ad your patients read, conclude that you now compete for their restorative work, and quietly move their cases to the surgeon who did not advertise to their patients. The full-arch revenue arrives. The dentoalveolar book that funded the practice for fifteen years starts leaking.
Already running full-arch ads? Jump to the trademark and claims sections—those are the fastest, highest-risk fixes. Building the program from scratch? Read in order.
The fix is not to market less. It is to market both audiences deliberately, with one published policy that keeps the two messages from contradicting each other. Below you’ll get the two-track model, the referral policy that resolves the conflict, the search-intent map for full-arch, the trademark and claims rules that quietly break most of these campaigns, and the one metric that should replace “leads” on your dashboard.
Written for: oral and maxillofacial surgeons, OMS practice administrators, and the marketing teams building full-arch programs inside surgical practices and specialty groups.
TL;DR
If you only take six things from this, take these:
| 1. |
Run two tracks, not one - a referral track aimed at general dentists and a patient track aimed at self-referred searchers, governed by one published restorative policy so the two never contradict each other
|
| 2. |
Publish where the case goes back - what drives referral loss is not the surgery, it’s the restorative and the recall; put your policy in writing and put it on the site where referrers can find it
|
| 3. |
Lead with sequence, not just credentials - a national investigation found most private-equity chain clinic pages list no surgical specialist, but the dedicated full-arch chains do; what they cannot copy is a clinician who examines the patient before anyone quotes a price
|
| 4. |
Fix the trademark problem in your URLs - All-on-4 is a registered mark with published usage rules that most full-arch site architectures violate on day one
|
| 5. |
Audit the gallery and the payment headline - patient before-and-after testimonials and monthly-payment offers are the two highest-risk assets in full-arch marketing, and both are regulated more tightly than most practices assume
|
| 6. |
Measure attended consults, not leads - the consult is the conversion event, and the ad platform’s import windows will not wait for your case starts |
Table of Contents
Why full-arch implant marketing breaks the oral surgery referral model
Most dental specialties market to one audience. Oral surgery marketing has to reach two, and full-arch is the procedure where their interests collide.
Audience one is the general dentist, who sends third molars, impactions, exposures, difficult extractions, biopsies, pathology, and trauma. That book is high-volume, low-acquisition-cost, and durable. It is also the majority of most surgical schedules.
Audience two is the self-referred patient with a failing dentition or an existing denture, who saw a television spot, has already priced two corporate centers, and is shopping for a third opinion. That patient is a five-figure, largely fee-for-service case.
The collision is structural, not emotional. A corporate full-arch center presents one team, one location, one quote, and teeth in a day. An oral surgeon, by training and by scope, owns the surgical phase of a two-provider treatment plan. When your marketing implies you deliver the whole arc—extraction through final prosthesis—you have made a promise that either understates your restorative partner or overstates your own scope. Either version reads to a referring dentist as: this practice is now competing for my patient.
What referrers are actually afraid of is rarely the surgery. It is the restorative work and the recall. A full-arch case does not end at osseointegration; it continues through the final prosthesis, occlusal adjustments, hygiene, and years of maintenance. A general dentist who sends you a full-arch case is handing over a patient who may never come back. Ambiguity about where that patient lands is the entire problem—and ambiguity is what most full-arch marketing creates.
A pattern we commonly see: the practice never intended to keep the restorative. Nobody wrote the policy down, the website said “your new smile, start to finish,” and three referrers drew the obvious conclusion. The marketing did not cause a business decision. It communicated one that was never made.
The stakes are asymmetric, and worth stating plainly. Full-arch is one procedure. Your referral base is the practice. Trading the second for the first is a bad trade even when the full-arch program works.
> Back to Table of Contents
The referral track: what actually earns full-arch cases from general dentists
Referral marketing is a real channel with real mechanics, not a lunch-drop budget line, and the surgeon-to-general-dentist relationship is the asset it builds. The research on what moves dental implant referrals is unusually consistent, and it points somewhere most practices are not spending.
A survey of 602 general dentists and specialists published in Compendium in 2018 examined what actually drives dental implant referrals. The authors found quality of work to be an important attribute, and found that distance to the general dentist’s office influenced implant referrals—but only significantly for practitioners in practice five years or less. Their review of the surrounding literature is blunter still: open communication appears critical to the general dentist and specialist referral system, and specialists who submit timely follow-up reports strengthen the relationship significantly. Translated into a budget: the highest-yield referral asset you own is a fast, clear case report—not a logo pen.
Build the referral track around four assets:
| 1. |
A published restorative policy - one page, written in plain English, stating exactly which cases you return to the referring dentist for restoration, which you co-treat, and under what conditions you would ever restore in-house
|
| 2. |
A case-report cadence with a named owner and a due time - post-operative report to the referrer within a defined window, every time, with the treatment plan, the imaging, and the next step spelled out
|
| 3. |
Shared digital planning - CBCT and treatment plan delivered to the referrer in a format they can open and discuss with the patient, so co-diagnosis happens before the patient is sold anything
|
| 4. |
Education that is genuinely useful - study clubs and continuing education on case selection, when full-arch is contraindicated, and how to hand off a case cleanly |
Notice what is not on that list: anything that looks like paying for referrals. Federal and state anti-kickback rules constrain remuneration tied to patient referrals, and the constraint tightens the moment federal healthcare program dollars are anywhere in the picture. Referral marketing that survives scrutiny is education and service, delivered consistently. Run any referral incentive or referral card program, marketing co-op, or revenue-sharing idea past healthcare counsel before it exists in writing.
The one document that resolves the conflict is the restorative policy, and it belongs on your public website—not in a drawer. Publishing it does three things at once: it removes the ambiguity that costs you referrals, it gives your team a script when a patient asks “can you just do all of it here,” and it becomes a page that referring dentists actually search for and read. A surgeon who will state in public where the case goes back is a surgeon a general dentist can send to.
> Back to Table of Contents
The patient track: what a self-referred full-arch patient is actually doing
The full-arch patient is not behaving like a dental patient. They are behaving like someone about to finance a used car from a stranger.
They have usually seen advertising first and a clinician second. They are shopping multiple consultations. They are afraid of two things in roughly equal measure: the cost, and being sold something they will regret permanently. And their research window runs weeks to months, not days—which has consequences for your tracking that we’ll get to.
Map the intent, then build to the gaps. Full-arch search splits into six layers, and most practices only build for one of them:
| • |
Condition and symptom - failing teeth, loose dentures, bone loss, “my dentist says I need everything out”
|
| • |
Solution and comparison - fixed versus removable, implant-supported denture versus fixed full-arch, zirconia versus acrylic hybrid, four implants versus six
|
| • |
Brand and alternative - national chain names paired with “alternatives,” “reviews,” “versus,” and “is it worth it”
|
| • |
Provider verification - who should place full-arch implants, oral surgeon versus general dentist, how to check board certification, will I meet the surgeon before surgery
|
| • |
Cost and financing - what drives the quote, what is included, what gets billed separately, how people pay for it
|
| • |
Failure and revision - broken prosthesis, failed implants, peri-implantitis, second opinions, fixing someone else’s case |
Layers one and two are saturated, and they are also where price shoppers cluster. Layers three through six are where the demand is qualified and the competition is thin. A surgeon is uniquely credible on provider verification and revision—those are the pages a corporate marketing department cannot write honestly, and they are exactly the pages a frightened five-figure buyer reads at eleven at night.
Revision content deserves a specific note. Patients whose full-arch work failed are searching, motivated, and largely unserved. They also arrive with a treatment plan that is genuinely surgical: assessing bone, managing hardware, salvaging or replacing. If you take those cases, publish about them. If you do not, publish about how to evaluate them anyway—it is the most trust-dense content in the category.
> Back to Table of Contents
The differentiator corporate full-arch centers cannot copy
In late 2024, KFF Health News and CBS News published a months-long investigation into full-arch and implant dentistry. Its central finding was that some practitioners were removing treatable teeth to make room for implants, with interviewed experts—including the dean of the Harvard School of Dental Medicine—describing second opinions in which the recommended full-arch treatment was not necessary. You can read the reporting at KFF Health News.
Buried in that investigation is the most useful competitive fact an oral surgeon has been handed in a decade. Reporters analyzed the webpages of more than 1,000 clinics inside the largest private-equity-owned dental chains, all of which offer some implants. More than 70 percent listed only general dentists and did not appear to employ oral surgeons, periodontists, or prosthodontists at all. One large denture-and-implant brand listed specialists at fewer than five percent of its 400-plus clinics.
Now the part most agencies get wrong, and it is the part that matters. The same analysis found that the chain built specifically around full-arch employs at least one oral surgeon or prosthodontist at every one of its 100-plus centers. So against your closest competitor, “we have a specialist” is not a differentiator. It is table stakes. What the reporting documents about that competitor is not a missing credential—it is a sequence. A dental malpractice attorney who said he has represented at least six of its former patients told reporters that every one of them met a salesperson, and signed up for financing, before they ever met a dentist. The patient whose lawsuit opens the investigation said she passed a credit check before a clinician ever looked in her mouth. The chain has denied wrongdoing in that pending case. The sequence is still the story, and the sequence is what you can beat.
That is where your structural advantage actually lives. Not “experience.” Not “technology.” Not the credential on its own. Specifically:
| • |
The surgeon you meet is the surgeon who operates - state it plainly, and mean it, because patients are now being coached to ask this question directly
|
| • |
Board certification is verifiable - a diplomate credential can be checked against a public directory, which is a different category of claim than “award-winning”
|
| • |
The clinician sees the patient before the quote does - the exam and the CBCT read happen before anyone discusses financing, and the person presenting the plan is not compensated on whether it is accepted
|
| • |
You will say no - publish the criteria under which you recommend against full-arch and toward preserving teeth, because a practice that documents when it declines is making a claim its competitors structurally cannot |
That last one is the whole strategy compressed into a sentence. In a category under national scrutiny for overtreatment, conservative-treatment content is not a hedge. It is the differentiator, it is defensible, and it works on both audiences at once—the patient reads it as honesty, and the referring dentist reads it as evidence you are not going to strip-mine their patient.
One constraint to resolve before any of this goes live. Specialty announcement is governed by state dental board advertising rules and, for members, by the ADA Principles of Ethics and Code of Professional Conduct. Section 5.F holds that no dentist shall advertise in a manner that is false or misleading in any material respect. Section 5.H governs announcement of specialization and includes language that a dentist who announces as a specialist limits their practice exclusively to the announced area—which is directly relevant if you are contemplating an in-house restorative arm and marketing a start-to-finish promise. State rules vary sharply: Michigan, for example, restricts a dentist from advertising as limiting practice to or being specially qualified in a branch of dentistry without board certification as a specialist, and boards have imposed penalties, suspensions, and prior-approval requirements on advertising that touted specialty status improperly. The ADA maintains an overview at its marketing and advertising resource. Get a written read from counsel and your board on your specific claim set before the campaign runs, not after.
> Back to Table of Contents
Full-arch search and AI visibility: where the wins actually are
Two things changed in the last eighteen months that should reallocate your budget, and they point in opposite directions.
Local provider searches are no longer an AI game. Google tested AI Overviews on local healthcare provider queries—the “near me” pattern—and then reversed course and removed them. Independent tracking put coverage on those queries at essentially 100 percent in 2023 and zero by the end of 2025. Searches for a local dentist or specialist now resolve through the map pack, Google Business Profile, and traditional organic listings. If someone sold you an “AI Overview strategy” for “oral surgeon near me,” they sold you optimization for a surface that does not exist on that query. Local acquisition is still won with profile completeness, category precision, review depth, proximity, and conventional local SEO.
Informational searches are almost entirely an AI game. That same tracking put AI Overview coverage on healthcare treatment and procedure queries at 100 percent by the end of 2025, up from roughly 45 percent in 2023, with symptom and condition queries in the low nineties. Full-arch is a treatment query. Your condition explainers, comparison pages, and procedure guides now compete inside the answer box, not below it—and month-to-month volatility in that coverage has flattened, which means this is settled behavior, not a test.
The tactical consequence is a split strategy. Two budgets, two content types, two scoreboards:
| • |
Local layer - Google Business Profile, service attributes, location pages that describe an actual location, reviews with procedure-specific language, and NAP consistency across healthcare directories and specialty boards
|
| • |
Informational layer - deep, current, clinically reviewed pages that answer a full question in extractable passages, refreshed on a schedule rather than published and abandoned |
What will not work anymore is volume. Google’s March 2026 core update rolled out over twelve days, finishing April 8, and the post-rollout pattern is unusually good news for a surgical practice. Independent visibility analysis found Google pulling back the aggregators, syndicators, and large consumer health publishers that have anchored medical results since 2018, and elevating the original, authoritative sources those publishers were citing. Health content carrying named, credentialed contributors and a visible review process gained ground; content without original expertise lost it. If you run templated location pages that swap a city name into otherwise identical copy, you are on the wrong side of that line; start with recovering rankings after an algorithm hit. Ten thin pages on full-arch produce zero citable passages. One deeply researched page with a named, credentialed surgical author produces several. For a specialty practice with a finite content budget, that is the whole game—depth is cheaper than sprawl.
Practical structure for citation: answer the question in the first two sentences of the section, in a self-contained way that makes sense without the headline above it. Attribute clinical content to the surgeon who reviewed it, with verifiable credentials on the page. Keep the publish and review dates honest and current. Those three habits do more for AI citation than any schema tactic.
> Back to Table of Contents
Trademark discipline: the All-on-4 problem hiding in your URLs
This is the section that makes people uncomfortable, so here it is directly: All-on-4® marketing has a trademark problem. The mark is registered to Nobel Biocare Services AG, and the way most full-arch dental websites are built violates the mark owner’s published usage guidelines before a single word of copy is written.
Nobel Biocare publishes those guidelines openly at its trademark page. The correct usage is straightforward: the mark is an adjective that modifies a generic noun, and the company’s own list pairs it with the generic term “treatment concept.” So the compliant reference is the All-on-4® treatment concept, spelled and capitalized exactly as shown, with an ownership attribution in your credits.
The prohibited uses are where the damage is:
| • |
Do not register the mark as a domain name or in any part of a URL - which is precisely what a full-arch page slug containing the mark and a city name does
|
| • |
Do not use the mark in social media account names, profiles, or aliases - the branded handle strategy runs straight into this
|
| • |
Do not use the mark in the plural or possessive - it is an adjective, so the casual copywriting habit of pluralizing it is out
|
| • |
Do not shorten or abbreviate the mark, or invent names that contain it - which is precisely what a practice does when it brands itself the All-on-4 center of its city
|
| • |
Do not imply affiliation, sponsorship, endorsement, certification, or approval without authorization - naming yourself after the mark implies all four at once, whether or not you meant it that way
|
| • |
Do not use the registration symbol where the mark is not registered - rights vary by country, and the symbol is not decoration |
Then there is the layer underneath the trademark, which is worse. If you advertise the mark and place a different manufacturer’s implant system, you have a truthfulness problem entirely independent of trademark law. The ADA Code’s advertising standard and the FTC’s deception authority both reach that conduct, and “everybody in our market does it” is not a defense to either.
The rebuild is not painful, and it is strategically better anyway. Own the generic clinical category as your ranking asset—full-arch implants, full-arch restoration, fixed full-arch, implant-supported full-arch—in your URLs, headings, and page architecture, the same way you would for any other high-value oral surgery procedure. That vocabulary is what the clinical literature uses, what a growing share of informed patients now search, and what nobody can send you a cease-and-desist over. Reference the branded treatment concept accurately, with the generic term and attribution, in the body copy of pages where it is clinically true that you use that system. You lose nothing in rankings. You remove a category of risk that sits, right now, in the address bar of most of your competitors.
> Back to Table of Contents
Claims discipline: what you can actually say about full-arch results
Full-arch marketing runs on before-and-after photographs and patient stories. Both sit inside the FTC’s advertising rules for dentists, both are governed more tightly than most practices believe, and the rules changed recently.
Testimonials and before-and-after galleries
The FTC’s Endorsement Guides, revised in 2023 with a new definition of “clearly and conspicuously,” take a position that surprises most dental marketers. An endorsement claiming a specific result is read to mean the endorser’s experience reflects what others can generally expect. And the Commission is explicit that disclaimers like “results not typical” or “individual results may vary” do not change that reading. Its guidance is published at the FTC’s endorsement guides FAQ.
That leaves two lawful paths, and only two: hold adequate substantiation that the depicted results are typical, or clearly and conspicuously disclose the generally expected performance in the circumstances shown. For full-arch, that means the standard testimonial—I got my teeth in one day and I can eat anything now—is a specific-results claim your disclaimer does not cure.
There is a second obligation almost nobody honors. If your site says or implies the endorser still uses the product, you may only run that endorsement while you have good reason to believe it is still true, and you are obligated to keep the claims accurate over time. For full-arch, that is not academic. A five-year-old gallery entry implies an arch that is still functioning. If that patient has since had a prosthesis fracture, an implant failure, or a revision, your marketing is now making a claim your chart contradicts.
The practical control: a scheduled gallery audit against the record, an expiration date on every consent, and a rule that any case in active revision comes down the same week. It is unglamorous. It is also the difference between a defensible file and a discoverable one.
Reviews after the Consumer Review Rule
The FTC’s rule banning fake and deceptive reviews took effect on October 21, 2024, and it is no longer theoretical: in December 2025 the Commission issued its first warning letters under the rule to ten companies. Violations carry five-figure civil penalties per violation, and each day of a continuing failure to comply can be treated as a separate violation. The Commission’s announcement is at the FTC’s final rule release.
Four practices that are common in dental marketing and now carry rule exposure:
| • |
Review suppression - removing, blocking, or withholding negative reviews, or displaying favorable ones in a way that distorts the overall picture
|
| • |
Insider reviews without disclosure - reviews or testimonials from officers, managers, employees, agents, or their immediate relatives that do not clearly and conspicuously disclose the relationship
|
| • |
Sentiment-conditioned incentives - anything that offers something in exchange for a review expressing a particular sentiment; a request phrased around how much they loved it is the pattern to kill
|
| • |
Company-controlled “independent” review sites - misrepresenting that a site or entity you control provides independent reviews of a category that includes your own services |
Note that this rule reaches conduct inside your practice, not just your agency’s work. A treatment coordinator asking a happy patient for a five-star review, or a marketing manager posting a review of their own employer, is exactly the fact pattern the rule was written for. Whoever handles your reputation management should be able to hand you the request template and the escalation path in writing.
> Back to Table of Contents
The two compliance rules most full-arch campaigns break
These two are not edge cases. In our experience auditing specialty practice marketing, they are close to universal—and both are cheap to fix before launch and expensive to fix after.
Patient photos and stories need a HIPAA authorization first
The HIPAA Privacy Rule requires a covered entity to obtain a written authorization for any use or disclosure of protected health information for marketing, with narrow exceptions for face-to-face communication and promotional gifts of nominal value. A valid authorization has required core elements: a specific description of the information, who may disclose it, who may receive it, the purpose, an expiration date or event, the signature, and required statements on revocation, treatment conditioning, and redisclosure. “They said it was fine” is not an authorization. Neither is a media release drafted for a different purpose.
This is actively enforced. On September 30, 2025, HHS’ Office for Civil Rights announced a settlement with five providers over a “success story” program that posted patient names, photographs, and condition, treatment, and recovery details to public websites without valid written authorizations. The investigation found the program had disclosed the information of 150 patients. The resolution required a six-figure payment, a two-year monitored corrective action plan, workforce retraining that expressly included marketing personnel, and notification of every affected individual. The announcement is at HHS.gov. A comparable action reached a provider posting testimonials with full names and photos as far back as 2016, so this is a settled enforcement posture, not a new one.
The part that catches practices off guard is the cascade. An unauthorized marketing disclosure is not only a privacy violation—it is a breach, which triggers breach notification duties. The remedy is not quietly deleting the post. It is telling every affected patient what happened.
Two operational rules follow. First, get the authorization at the time of treatment, when the patient is excited about the result and the consent is contemporaneous with the record—not months later when marketing is assembling a campaign. Second, a marketing vendor that touches patient data is almost certainly a business associate, which makes a business associate agreement non-optional. In March 2026, OCR settled with a software company it described as focused on helping oral healthcare professionals market, manage, and grow their practices; the resolution agreement classifies that company as a business associate outright. The findings were an impermissible disclosure affecting roughly 15 million individuals after an intruder reached its systems, no adequate risk analysis, and—the part that should get your attention—a failure to notify the covered entities whose patients were exposed. Those practices did not hear it from their vendor. The announcement is at OCR’s settlement page. Ask your vendor, in writing, what its breach-notification duty to you actually is.
The monthly-payment headline is a regulated credit advertisement
“New teeth for as little as a low monthly payment” is the most common full-arch headline in America, and it is where patient financing collides with consumer credit law: stating an actual figure turns that ad into a regulated credit advertisement under Regulation Z.
Under the closed-end credit advertising rule, certain terms trigger mandatory additional disclosures: the amount or percentage of a downpayment (where one is actually required), the number of payments or period of repayment, the amount of any payment, and the amount of any finance charge. State any one of them and the advertisement must also disclose the downpayment, the terms of repayment, and the annual percentage rate—along with a statement that the rate may increase after consummation, if it can. The rule is published by the CFPB at Regulation Z section 1026.24.
Three details that decide most real cases:
| • |
The trigger does not have to be explicit - if the payment amount can be readily determined from the ad, the disclosures are still required
|
| • |
Vague payment language does not trigger - phrases like “monthly payments to suit your needs” or “regular monthly payments” are not statements of an amount, which is exactly why they are the safe default for a hero headline
|
| • |
You do not have to be the lender - the CFPB’s official interpretations state that all persons must comply with the advertising provisions, not just those meeting the definition of creditor, and that merchants who are not themselves creditors must comply if they advertise consumer credit transactions |
That third point is the one practices get wrong. Routing the loan through a third-party patient lender does not move the advertising obligation off your landing page. If your page states the payment figure, your page carries the disclosure duty—in close proximity, not in a footer nobody reads.
> Back to Table of Contents
Measure attended consults, not leads
Full-arch is where lead-count reporting fails most completely. A practice can double its lead volume, halve its cost per lead, and start fewer cases—because a cheap full-arch lead is usually a patient who cannot be treated, cannot pay, or was never going to show. No attribution model fixes a metric that is measuring the wrong event.
The conversion event is the attended consult. Not the form fill, not the call, not the booking. The number that should sit at the top of a full-arch dashboard is cost per attended consult, with consult-to-treatment-plan and plan-to-case-start underneath it.
Track the full sequence, one owner, one final outcome:
| • |
Inquiries - calls, forms, and messages, deduplicated across the multi-touch journeys that are normal in this category
|
| • |
Qualified - meets your clinical and financial screening criteria before anyone books an operatory
|
| • |
Consults booked - the appointment exists
|
| • |
Consults attended - the patient is in the chair; this is the number your ad spend should be judged against
|
| • |
Plans presented - a treatment plan was actually delivered
|
| • |
Cases started - surgery scheduled and deposit taken |
Now the platform constraint nobody warns you about. Google’s recommended path for feeding offline outcomes back into Google Ads is enhanced conversions for leads, which supplements the click identifier with hashed first-party data. Two platform changes landed this year: as of June 15, 2026 those uploads migrate to the Data Manager API and are blocked in the Google Ads API, and since April 2026 the separate enhanced-conversions settings for web and leads have been merging into a single switch. Here is the sharp edge: Google’s own guidance states that offline conversions for enhanced conversions for leads uploaded more than 63 days after the associated last click will not be imported. Their documentation is at Google’s offline conversion import guidelines.
Read that against a full-arch decision cycle that routinely runs a quarter or longer, and the conclusion is unavoidable: your case starts will frequently fall outside the window your bidding algorithm can see. So stop trying to make the algorithm optimize toward them. Feed the platform the attended consult—a real, qualified, in-window signal with enough volume for smart bidding to learn from—and keep case starts, revenue, and true source attribution in your own system, reported on a rolling window that matches how patients actually decide.
Two supporting mechanics. Mark the attended consult as a key event in GA4, since key events are what the platform now calls what it used to call conversions. And capture the click identifier into a hidden form field and store it against the patient record at first contact, because a signal you never captured cannot be imported at any deadline.
> Back to Table of Contents
Your first 90 days
Sequence matters here. Compliance and policy come before spend, because the assets you build in month one are the ones you would otherwise have to tear down in month four.
| 1. |
Days 1–30: decide and document - write the restorative policy, get counsel and your board to sign off on your specialty and scope claims, audit every URL and social handle for trademark exposure, and pull any testimonial or gallery entry without a valid, current authorization on file
|
| 2. |
Days 31–60: build the assets nobody else has - publish the restorative policy, the provider-verification page, the when-we-recommend-against-full-arch page, and the revision-evaluation page; stand up the case-report cadence with a named owner and a due time
|
| 3. |
Days 61–90: turn on measurement, then spend - capture the click identifier at first contact, mark the attended consult as your key event, wire the offline import, then start paid with a narrow geography and a single qualified offer |
Do not invert this. Every practice that launches ads first spends the next two quarters rebuilding under pressure, with a referral base already annoyed and a gallery already published. The order above is slower for six weeks and faster for two years.
> Back to Table of Contents
Talk to WEO Media about your full-arch program
WEO Media - Dental Marketing builds full-arch and dental implant marketing programs for oral and maxillofacial surgery practices with both audiences in view: the referring dentists who fill your surgical schedule and the self-referred patients who fund your growth. If you want a read on where your current program sits on the risks and gaps above, call 888-246-6906 or schedule a consultation, and we’ll walk your site, your claims, and your measurement with you.
> Back to Table of Contents
FAQs
How do oral surgeons market full-arch implants without losing general dentist referrals?
Run two tracks governed by one published restorative policy. The referral track earns general dentist cases through fast, consistent case reports and shared digital treatment planning; research on implant referral patterns consistently points to communication and timely follow-up reports as the strongest drivers of the relationship. The patient track reaches self-referred searchers. The policy is what keeps them from contradicting each other: state publicly which cases you return to the referring dentist for restoration, which you co-treat, and under what conditions you would restore in-house. Referral loss is caused by ambiguity about where the patient lands after surgery, not by the existence of patient-facing advertising.
Can an oral surgeon advertise All-on-4?
All-on-4 is a registered trademark of Nobel Biocare Services AG, and the owner publishes usage guidelines. Correct use treats the mark as an adjective paired with its generic term, spelled and capitalized exactly, with an ownership attribution. The published guidelines prohibit registering the mark as a domain name or using it in any part of a URL, using it in social media account names or profiles, using it in plural or possessive form, shortening or abbreviating it or inventing names that contain it, and implying affiliation, sponsorship, endorsement, certification, or approval without authorization. Separately, advertising the mark while placing a different manufacturer’s implant system raises a truthfulness problem under the ADA advertising standard and FTC deception authority regardless of trademark law. Most practices are better served building URL and heading architecture around generic terms like full-arch implants.
Do I need a HIPAA authorization to post a full-arch before-and-after photo?
Yes. The HIPAA Privacy Rule requires a written authorization for any use or disclosure of protected health information for marketing, with narrow exceptions for face-to-face communication and promotional gifts of nominal value. The authorization must contain required core elements including a specific description of the information, who may disclose and receive it, the purpose, an expiration date or event, a signature, and statements on revocation, treatment conditioning, and redisclosure. This is actively enforced: in September 2025 HHS’ Office for Civil Rights settled with providers over a website success-story program that posted 150 patients’ information without valid authorizations, requiring a six-figure payment, a two-year corrective action plan, marketing staff retraining, and notification of every affected individual. Unauthorized marketing disclosures also trigger breach notification duties.
Is it legal to advertise a monthly payment for full-arch implants?
It is legal, but stating an actual payment figure makes the ad a regulated credit advertisement under Regulation Z. Triggering terms include the amount of any payment, the number of payments or period of repayment, the amount of any finance charge, and the downpayment amount where one is required. Stating any of them requires disclosing the downpayment, the terms of repayment, and the annual percentage rate in close proximity. The trigger applies even when the amount is not stated explicitly but can be readily determined. Vague phrases such as monthly payments to suit your needs are not triggering terms. Critically, the CFPB’s official interpretations state that merchants who are not themselves creditors must comply if they advertise consumer credit, so routing the loan through a third-party patient lender does not move the disclosure obligation off your landing page.
What is the right cost metric for full-arch implant marketing?
Cost per attended consult, with consult-to-plan and plan-to-case-start reported underneath it. Cost per lead is actively misleading in full-arch because cheap leads are disproportionately patients who cannot be treated, cannot pay, or never show. Track the full sequence with one owner and one final outcome per inquiry: inquiries, qualified, consults booked, consults attended, plans presented, cases started. The attended consult is the earliest point at which the marketing has demonstrably done its job, and it is the only qualified signal that reliably occurs inside ad platform attribution windows.
Do AI Overviews appear for oral surgeon near me searches?
No. Google tested AI Overviews on local healthcare provider queries following the near me pattern, then reversed course and removed them. Independent tracking put coverage on those queries at essentially 100 percent in 2023 and zero by the end of 2025. Those searches resolve through the map pack, Google Business Profile, and traditional organic listings, which means local acquisition is still won with profile completeness, category precision, review depth, proximity, and conventional local SEO. Informational healthcare queries are the opposite: the same tracking put AI Overview coverage on treatment and procedure searches at 100 percent by the end of 2025, up from roughly 45 percent in 2023, with symptom and condition searches in the low nineties. Full-arch is a treatment query, so the two layers need separate strategies.
How does the length of the full-arch decision cycle affect ad tracking?
It breaks naive conversion tracking. Google’s guidance states that offline conversions for enhanced conversions for leads uploaded more than 63 days after the associated last click will not be imported into Google Ads. Full-arch decision cycles routinely run a quarter or longer, which means a meaningful share of case starts fall outside the window the bidding algorithm can ever see. The workable approach is to optimize bidding toward the attended consult, which occurs inside the window and carries enough volume for smart bidding to learn from, while keeping case starts, revenue, and true source attribution in your own system on a rolling window that matches real patient behavior.
Should an oral surgery practice publish content about when full-arch is the wrong treatment?
Yes, and it is arguably the highest-leverage content a surgical practice can publish. A 2024 KFF Health News and CBS News investigation found that some practitioners were removing treatable teeth to make room for implants, and that an analysis of more than 1,000 clinic webpages inside the largest private-equity-owned dental chains found more than 70 percent listed only general dentists with no oral surgeons, periodontists, or prosthodontists. In a category under that scrutiny, publishing your criteria for recommending against full-arch is a claim high-volume competitors structurally cannot make. It also works on both audiences at once: patients read it as honesty, and referring general dentists read it as evidence you will not overtreat their patient. |
|
